Related Experiment Video
Updated: Aug 1, 2025

08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
10.1K
Phosphorothioated DNA Engineered Liposomes as a General Platform for Stimuli-Responsive Cell-Specific Intracellular
An Yan1, Xiaoqing Chen1, Jie He1
1School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, China.
Angewandte Chemie (International Ed. in English)
|April 26, 2023
Summary
Researchers developed a novel DNA-coated liposome system for precise intracellular protein delivery. This technology enables targeted and controllable protein release into specific cells, advancing cell therapy applications.
Area of Science:
- Biotechnology
- Nanomedicine
- Cellular Biology
Background:
- Intracellular protein delivery is crucial for protein drug-based cell therapy.
- Current methods lack specificity and efficiency in delivering proteins to target cell cytoplasms.
- Existing fusogenic liposome systems have limited cell-specific and controllable delivery capabilities.
Purpose of the Study:
- To design a novel system for cell-specific and controllable cytosolic protein delivery.
- To mimic viral fusion mechanisms for enhanced intracellular delivery.
- To overcome limitations of existing protein delivery technologies for cell therapy.
Main Methods:
- Development of a fusogenic liposome system modified with phosphorothioated DNA coatings.
- Design of a macromolecular fusion machine to dock liposomes to target cell membranes.
- Stimulation of membrane fusion using pH or UV light triggers for protein release.
Main Results:
- Demonstrated efficient cell-targeted delivery of proteins with varying sizes and charges.
- Confirmed the ability of phosphorothioated DNA coatings to facilitate spatial-temporally controlled protein delivery.
- Showcased the system's efficacy for both in vitro and in vivo applications.
Conclusions:
- The developed DNA-coated fusogenic liposome system offers a general strategy for targeted protein delivery.
- This approach enables precise control over protein release into specific cell populations.
- The technology holds significant potential for advancing protein drug-based cell therapies.

